Antiepileptic Drug Use

Project Title Antiepileptic Drug Use
Date Posted
Wednesday, November 20, 2013
Project ID
MSY4_MPR28
Status
Complete
Deliverables
Description

Modular program-based one-time assessment of the use of antiepileptic drugs (AEDs), including acetazolamide, carbamazepine, clobazam, clonazepam, diazepam, ethosuxamide, ezogabine, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, lorazepam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, primidone, rufinamide, tiagabine, topiramate, valproic acid, vigabatrin, and zonisamide.   Incident use was determined 1) with respect to an AED of interest, rather than all AEDs, and 2) with respect to all AEDs, rather than a specific AED of interest. Modular programs are adaptable standardized programs. Results were generated using Modular Program 2, version 3.1; click here for more information. Programs were executed in April 2011.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
acetazolamide
carbamazepine
clobazam
clonazepam
diazepam
ethosuxamide
ezogabine
felbamate
gabapentin
lacosamide
lamotrigine
levetiracetam
lorazepam
oxcarbazepine
phenobarbital
phenytoin
pregabalin
primidone
rufinamide
tiagabine
topiramate
valproic acid
vigabatrin
zonisamide
Time Period
2004 - 2012
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER